EMVision: Recommences clinical trial enrolment
- Medical imaging company EMVision has recommenced enrolling patients in its clinical study at Brisbane’s Princess Alexandra Hospital
- The study is testing EMV’s portable brain imaging device in stroke patients
- The company also says it is continuing to monitor the COVID-19 situation, and any associated impacts on its trial work
- This includes access to clinical facilities and personnel which may diverted due to pandemic-related public health needs
- EMVision says it will continue to provide updates to the market as the situation progresses and further clinical milestones reached
- EMVision is down 2.7 per cent to 89 cents per share as at 12 pm AEST
